It’s no secret that virtually everyone on earth needs a vaccine for COVID-19, but imagine having to organize the development, production, and distribution. Few companies have to climb that logistical mountain, one of which is Moderna Therapeutics. According to a recent FiercePharma article, the drugmaker has raised its 2021 base-case production estimate from 500 million to 600 million doses, and could potentially hit 1 billion doses. The massive supply goals are in response to increased demand as Moderna recently received expanded orders from Canada, the U.S. and the EU.
Moderna Eyes 1B COVID-19 Vaccine Doses This Year
Moderna Therapeutics is dialing up its low-end manufacturing predictions for the year.
Jan 8, 2021
Recommended
Recommended
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
